Ujházy V, Reiner P, Farkas J, Skoda J
Neoplasma. 1977;24(3):259-61.
2.3-Dihydro-1,3-6H-oxazine-dione ("3-oxauracil") was tested against L1210 leukemia. The compound exhibited significant growth-inhibiting effect against this tumor both in vitro and also in vivo following daily intraperitoneal application.